UCB Ventures

UCB Ventures is an evergreen strategic corporate venture fund established in 2017, with offices in Boston, Brussels, and London. The fund aims to create value from novel insights and technologies that can transform the lives of patients suffering from severe diseases. UCB Ventures focuses on long-term investments in early-stage companies, particularly those developing innovative therapeutic modalities and platforms that address novel biology. Its investment strategy emphasizes a thoughtful and sophisticated approach while maintaining speed and agility, targeting areas such as next-generation cell and gene therapy, regenerative medicine, and RNA modulation.

UCB Ventures leverages its strategic ties to UCB Pharma to provide not only financial support but also access to industry expertise, resources, and networks that can accelerate the growth of portfolio companies. This includes guidance on navigating regulatory landscapes and insights into market needs in the therapeutic space.